LSIPR 50 2017: John Mendlein

10-11-2017

John Mendlein was selected in the LSIPR 50 2017 publication for his influence on the life sciences industry. He featured in the business and innovation section, as LSIPR reports.

Name: John Mendlein

Organisation: aTyr Pharma

Position: CEO


John Mendlein, aTyr Pharma, physiocrines, cellular activities, immune system, tissue damage, autoimmune, BIO

LSIPR